Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preferred RNA binding sites for a threading intercalator revealed by in vitro evolution.

Coby B Carlson1, Momchilo Vuyisich, Barry D Gooch

  • 1Department of Chemistry, University of Utah, Salt Lake City, UT 84112, USA.

Chemistry & Biology
|August 2, 2003
PubMed
Summary

Peptide-acridine conjugates (PACs) selectively bind RNA aptamers, not DNA. Researchers identified specific RNA structures, including a 5’-CpG-3’ sequence, that enhance PAC binding affinity for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Human Gut Microbiome Activity Is Resilient and Stable for up to Six Months: A Large Stool Metatranscriptomic Study.

Microorganisms·2026
Same author

Synthesis of 2'-O,4'-Cα-Dimethyl Ribonucleoside Analogs and Their Effects on RNA and Modulation of ADAR Editing.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Discovery and Tuning of RNA Editing Guides via High-Throughput Screening and Chemical Modification.

Chembiochem : a European journal of chemical biology·2025
Same author

Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights.

BMC gastroenterology·2025
Same author

Clickable RNA via 4'-<i>C</i>-Ethynyl Cytidine─A Novel Design for Metabolically Stable Guide RNAs in RNA Editing.

Bioconjugate chemistry·2025
Same author

Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation.

Small (Weinheim an der Bergstrasse, Germany)·2025

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • RNA Therapeutics

Background:

  • Small molecules targeting RNA are crucial for controlling gene expression.
  • Peptide-acridine conjugates (PACs) are investigated for their RNA-binding capabilities.
  • Understanding PAC-RNA interactions is key to developing novel therapeutics.

Purpose of the Study:

  • To explore the RNA binding properties of peptide-acridine conjugates (PACs).
  • To identify specific RNA sequences and structures that bind PACs with high affinity.
  • To assess the selectivity of PACs for RNA over DNA.

Main Methods:

  • Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was employed to isolate RNA aptamers.
  • Characterization of PAC-RNA binding affinities and selectivity.

Related Experiment Videos

  • Analysis of RNA structural motifs recognized by the PAC.

    • Main Results:

    • PACs demonstrated selective binding to RNA aptamers with high discrimination against DNA.
    • The preferred binding site involves a base-paired 5’-CpG-3’ sequence, a known intercalation site.
    • RNA secondary structures flanking the CpG site significantly modulate binding affinity, with optimal affinity (K(D) = 20 nM) observed for a specific loop-bulge motif.
    • Potential binding sites were identified in viral 5'- and 3'-untranslated regions (UTRs).

    Conclusions:

    • PACs are effective RNA-targeting molecules with high selectivity.
    • RNA sequence and structure critically influence PAC binding affinity.
    • The identified PAC and its preferred binding motif offer a foundation for designing RNA-targeted drugs.